We are delighted to confirm that the PMI Annual Pharma Summit is returning to the Croke Park conference centre on Thursday April 18th, 2024.
We’re really looking forward to welcoming all our members and guests to what promises to be a day packed with insights and information that you can bring back to your teams and apply in your day-to-day work. The agenda for the day will examine the diverse values in healthcare across patients and payors.
Speakers:
(in alphabetical order)
Bernard Duggan, Chief Pharmacist – Medicines Management Programme (HSE)
Bernard is Chief I Pharmacist in the HSE-Medicines Management Programme. His work involves delivery and oversight of health technology management programmes in the Irish healthcare service, that is, measures put in place to enhance the safe, effective and cost-effective use of medicines on a national level.
Bernard’s role includes leading the best-value biological medicine initiative, which has focused on increasing the prescribing and utilisation of biosimilar medicines, including TNF-α inhibitors (adalimumab and etanercept) and teriparatide. In addition, he has led the development and implementation of managed access processes to facilitate reimbursement of innovative medicines.
Bernard obtained his undergraduate pharmacy degree from Trinity College Dublin, and registered as a pharmacist in 2005. In addition, he has been awarded diplomas in project management and health economics. He has previously worked in both community pharmacy and regulatory roles.
Neil Grubert, Global Market Access Consultant, Trainer and Writer
Neil is a pharmaceutical market access specialist with more than 20 years of experience tracking access environments around the world. He advises leading biopharmaceutical companies on the implications of international access trends and has authored more than 150 reports on the subject. Neil also delivers multi-client and bespoke training programmes with a focus on pricing, reimbursement and market access trends around the world.
Prof Orla Hardiman – Professor of Neurology, Head of the Academic Unit of Neurology and Academic Director of Trinity Biomedical Sciences Institute, and Consultant Neurologist at Beaumont Hospital.
Orla has been HSE Clinical Lead in Neurology from 2019-2023. She is a science and medical graduate from UCD and trained in Neurology in Boston. She is the Director of the National ALS Clinic at the National Neuroscience Centre, Beaumont Hospital Dublin Ireland, where she provides clinical care for over 80% of Irish patients with Amyotrophic Lateral Sclerosis (ALS) .
She is the author of over 470 peer reviewed publications and editor of a textbook of Neurodegeneration. Her research group comprises over 5 individuals and her interests include the epidemiology, phenotype, biomarker discovery and genetics of ALS and related neurodegeneration.. She is Co- Chair of the European Network for Cure of ALS (ENCALS) and is editor in chief of the journal Amyotrophic Lateral Sclerosis and the Frontotemporal Degenerations, and a founder of the Neurological Alliance of Ireland and the Irish Brain Council. She is the Lead Investigator of the SFI funded Academic/ Industry Programme PRECISION ALS.
She is the recipient of a number of international and national honours and awards including the AAN Sheila Essey Award in ALS Research and the International ALS Alliance Forbes Norris Award, the Tom Connor Distinguished Investigator Award in Neuroscience, The Trinity College Innovation Award, The SFI Researcher of the Year Award, and the HRB Research Impact Award.
Emma Lynch, Founder – EQ Vibration
Emma specialises in helping medical affairs professionals to inspire joy, harmony and innovation in their career through emotional intelligence education. Using her Thrive method, Emma equips medical affairs professionals with tools and principles to strengthen their relationship with themself and build a more focused, creative passionate career.
Emma received a B.A in Biochemistry from University College Dublin Ireland, a Ph.D. in Cell & Molecular Biology from University of Notre Dame, IN, USA and a MSc in Pharmaceutical Medicine from Trinity College Dublin, Ireland. She has gained over 15 years experience as a Medical Director in the pharmaceutical industry having worked for Pfizer, Astellas and UCB in Ireland. Emma maintains a data analytics company, runs emotional intelligence workshops for medical affairs departments and consults for organisations.
David McMahon, CEO – Irish Skin Foundation & Chair – IPPOSI
Appointed CEO of the Irish Skin Foundation in 2017, David’s background includes health advisory, government relations, and public affairs, having worked in Diabetes Ireland, the Department of Health, and in Dáil Éireann. David has been a member of the board of Global Skin (the International Association of Dermatology Patient Organisations /IADPO) since 2015, chairperson of Irish Platform for Patient Organisations, Science and Industry (IPPOSI) since 2021, and holds a BA in history and politics from the University of Limerick (UL), an MA in history from UCD, and an MSc in business leadership & management practice from UCD Smurfit Business School.
Paul Pierotti, Partner, Data Analytics & AI Practice – EY Ireland
Paul brings 25 years of experience in applying Data Analytics to improve strategic decisions and business outcomes. This typically involves working with an organisation’s leadership team to define their Analytics and AI vision and business case by use case. He then helps build the related assets that are embedded in operational processes to realise that value. He has delivered over 50 successful engagements in Health and Life Sciences, including using data to improve Health Care Professional and Patient engagement. Paul has a BSc in Mathematics and MSc in Industrial Mathematics.
Dr Lesley Tilson, Chief I Pharmacist – National Centre for Pharmacoeconomics (NCPE)
Dr Lesley Tilson is a graduate of the University of Brighton. She trained in the Chelsea and Westminster hospital, London and then worked as a resident pharmacist at the Oxford Radcliffe Hospitals NHS Trust. During this time she completed a Diploma in Clinical Pharmacy with Cardiff University. Lesley worked as a senior clinical pharmacist at St James’s Hospital Dublin, on the intensive care unit and cardiac surgery ward. She has a PhD from the Department of Pharmacology and Therapeutics, Trinity College Dublin (2002-2005) and a Diploma in Statistics from Trinity College Dublin (2003-2004). She is a lecturer in pharmacoeconomics to undergraduate and postgraduate pharmacy students. Research interests include: Economic evaluation of pharmaceuticals in the Irish setting, pharmaceutical pricing and reimbursement strategies, policies to promote generic markets, international pharmaceutical pricing, analysis of drug utilisation and expenditure trends. She received the ISPOR Bernie O’Brien New Investigator Award in May 2011.
——
Panel Discussion:
In the afternoon session, we will have an engaging panel discussion drawing on a diverse panel of experts representing patients, policy and industry.
Our esteemed panel of experts will discuss the topic of “Payers and Providers: The Value of Partnership. Striking the balance between innovation, affordability and continuity of supply”.
Our panel discussion will be chaired by Brenda Dooley, CEO with AXIS Consulting and includes:
- Caitriona Duggan, Country Manager – Amgen & Market Access Advisory Forum Lead – IPHA
- Deirdre Kelly, Country Manager: Ireland & Malta – Consilient Health & Vice Chair, Medicines for Ireland
- Carl Prescott, Head of HTA Consulting, UK – AXIS Consulting
- Angela Clayton-Lea, Acting CEO – Cancer Trials Ireland
The Pharma Summit is proudly supported by the following organisations:
Platinum Sponsor:
Gold Sponsors:
